Liberum Capital Reaffirms “Buy” Rating for Medicx Fund (MXF)
Separately, Peel Hunt cut Medicx Fund to a reduce rating and dropped their price objective for the stock from GBX 78 ($1.02) to GBX 72 ($0.94) in a research note on Tuesday, May 22nd.
Shares of Medicx Fund stock opened at GBX 0.77 ($0.01) on Wednesday. Medicx Fund has a 12-month low of GBX 76.75 ($1.00) and a 12-month high of GBX 92.50 ($1.20).
Medicx Fund Company Profile
MedicX Fund Limited ("MXF", "MedicX Fund", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom and Ireland, listed on the London Stock Exchange, with a portfolio comprising 154 properties.
Featured Story: Tariff
Receive News & Ratings for Medicx Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicx Fund and related companies with MarketBeat.com's FREE daily email newsletter.